Showing 5,121 - 5,140 results of 47,671 for search '"reporter"', query time: 0.12s Refine Results
  1. 5121
  2. 5122
  3. 5123

    PRIMER REPORTE DE Cryptosporidium parvum EN TERNEROS HOLSTEIN (Bos taurus) DE MANIZALES, CALDAS, COLOMBIA4 by R. J. Ocampo, F. A. Rivera, G. A. López, M. E. Álvarez, L.A. Cardozo, J. E. Pérez

    Published 2012-01-01
    “…Este hallazgo sugiere que el ganado puede ser una fuente potencial de infección por Cryptosporidium en humanos y se constituye en el primer reporte publicado de C. parvum en bovinos de Manizales, Caldas.…”
    Get full text
    Article
  4. 5124

    End-Of-Life Care for Persons with Advanced Chronic Obstructive Pulmonary Disease: Report of a National Interdisciplinary Consensus Meeting by DM Goodridge, DD Marciniuk, D Brooks, A van Dam, S Hutchinson, P Bailey, S Baxter, P Dorasamy, S Dumont, S Hassan, P Hernandez, A Kerigan, G Rocker, D Wilson, J Young

    Published 2009-01-01
    “…To address the needs of Canadian patients, an interdisciplinary consensus meeting, funded by the Canadian Institutes of Health Research and supported by the Canadian Thoracic Society, the Canadian Respiratory Health Professionals and the Canadian Lung Association was convened in Toronto, Ontario, on November 22, 2008, to begin examining the quality of end-of-life care for individuals with COPD in Canada. The present report summarizes the background to and outcomes of this consensus meeting.…”
    Get full text
    Article
  5. 5125

    Intravascular large B-cell lymphoma of the central nervous system with renal involvement: a case report and literature review by Jun Li, Zhaojiao Li, Yifeng Shi, Jiajie Chen, Heng Zhao, Xueye Mao, Shan Li, Huiying Wang, Qiang Meng, Lingchun Liu

    Published 2025-01-01
    “…The clinical manifestations and imaging of this disease are nonspecific, making diagnosis challenging. We report a case of a patient with recurrent stroke-like symptoms, primarily characterized by hemiplegia, vertigo, ataxia, and proteinuria. …”
    Get full text
    Article
  6. 5126
  7. 5127
  8. 5128
  9. 5129
  10. 5130

    Case Report: Management of a case of multidrug-resistant Klebsiella pneumoniae infection in a second-kidney transplant patient by Supreeta R. Shettar, Mahadevaiah Neelambike Sumana, Manjunath S. Shetty, Yogeesh D. Maheshwarappa, Reddy G. Raghukanth, Asha Srinivasan, Dharan P. Vamshi, Gautam Kalyatanda, Swamy G. S. Veerabhadra, Shylaja Eshwarappa Chinchana

    Published 2025-01-01
    “…This case report on recurrent urinary tract infections (UTIs) caused by multidrug-resistant (MDR) Klebsiella pneumoniae in a post-renal transplant patient underscores the significant clinical challenge of managing MDR infections in immunocompromised individuals, particularly in the context of renal transplantation. …”
    Get full text
    Article
  11. 5131
  12. 5132

    Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016) by Piotr Ozieranski, Emily Rickard, Shai Mulinari, Marcell Csanádi

    Published 2020-09-01
    “…Objectives To examine the under-reporting of pharmaceutical company payments to patient organisations by donors and recipients.Design Comparative descriptive analysis of payments disclosed on drug company and charity regulator websites.Setting UK.Participants 87 donors (drug companies) and 425 recipients (patient organisations) reporting payments in 2012–2016.Main outcome measures Number and value of payments reported by donors and recipients; differences in reported payments from/to the same donors and recipients; payments reported in either dataset but not the other one; agreement between donor–recipient ties established by payments; overlap between donor and recipient lists and, respectively, industry and patient organisation data.Results Of 87 donors, 63 (72.4%) reported payments but 84 (96.6%) were mentioned by recipients. …”
    Get full text
    Article
  13. 5133
  14. 5134
  15. 5135
  16. 5136

    The interaction between nirmatrelvir/ritonavir and sirolimus: a case report of a kidney recipient with renal insufficiency and COVID-19 by Yinhua Gong, Dan Shen, Jinfang Shi, Ye Jiang, Jie Gao

    Published 2025-01-01
    “…Nirmatrelvir/ritonavir is a novel drug combination authorized by the US Food and Drug Administration for the treatment of coronavirus disease 2019 (COVID-19). This report describes the case of a patient with a prior history of kidney transplantation who received nirmatrelvir/ritonavir. …”
    Get full text
    Article
  17. 5137
  18. 5138
  19. 5139
  20. 5140